What's Happening?
CKYN LLC, a skincare company based in Kirkland, Washington, has launched The Complete CKYN Protocol, a three-step skincare system centered around GHK-Cu (Copper Tripeptide-1). This system is designed to deliver visible skin improvements by using six primary
bioactives, each selected for their documented efficacy in cosmetic science. The protocol includes a Morning GHK-Cu Perfecting Lotion, a Daytime GHK-Cu Tallow Balm, and a Night-Time GHK-Cu Firming Serum, all formulated to provide consistent application throughout the day. CKYN emphasizes the importance of concentration in their formulations, ensuring that the levels of GHK-Cu used are consistent with those found effective in published research. The products are manufactured in the United States and are available for purchase on the company's website.
Why It's Important?
The launch of The Complete CKYN Protocol highlights a growing trend in the skincare industry towards transparency and efficacy. By focusing on the concentration of active ingredients, CKYN addresses a common issue in the industry where products may list beneficial ingredients without using them in effective amounts. This approach could set a new standard for skincare products, encouraging other companies to prioritize ingredient concentration and scientific backing. The use of GHK-Cu, a well-researched peptide, positions CKYN as a leader in evidence-based skincare, potentially influencing consumer expectations and industry practices.
